Sort by
Refine Your Search
- 
                Listed
 - 
                Category
 - 
                Employer
- University of Nottingham
 - KINGS COLLEGE LONDON
 - UNIVERSITY OF SOUTHAMPTON
 - Nature Careers
 - UCL;
 - University of Birmingham
 - ;
 - Brunel University
 - Cardiff University
 - EMBL-EBI - European Bioinformatics Institute
 - King's College London
 - Plymouth University
 - SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
 - Technical University of Denmark
 - The University of Edinburgh;
 - UNIVERSITY OF MELBOURNE
 - UNIVERSITY OF SURREY
 - University of Southampton;
 - University of Sussex;
 - 9 more »
 - « less
 
 - 
                Field
 
- 
                
                
                
population genetics, bioinformatics, computational biology, statistics or probabilistic machine learning and computer science. Experience of working with large genotyping or sequencing data sets A proven
 - 
                
                
                
, statistical genetics, genomics, genetic epidemiology, and bioinformatics as well as in-depth knowledge of genomics and relevant software. The candidate will be required to demonstrate relevant research and
 - 
                
                
                
proficient with microbial genetics, molecular microbiology, basic tissue culture and molecular biology techniques. Prior experience with bioinformatics (microbial sequencing and proteomics) would be
 - 
                
                
                
scientific boundaries and overcome hurdles. They will have experience in stem cell culture, imaging, molecular biology, genetic engineering and/or bioinformatics analysis. This will enable new approaches
 - 
                
                
                
Screening, biochemical and biophysical assay development, Bioinformatics, Depmap, TCGA, Computational Biology. Growing national reputation within academic field Proven substantial record of publications in
 - 
                
                
                
, neuroimaging, neurophysiology, proteomics, transcriptomics, epigenomics, metabolomics, bioinformatics, cell models and animal models. First in man and Phase 2, 3 and 4 clinical trials are also strongly supported